US$ 20.46
pnb-0408 dihexa clinical trial human Dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects dihexa science.bio Dihexa (PNB-0408) |
Description
Another mechanism of action of BPC-157 is blocking the inhibitory growth factor called 4-hydroxynonenal, which is a negative modulator of growth

10.1038/nrd2590 34 EngenK.RosenstrmU.AxelssonH.KondaV.DahllundL.OtrockaM.et al (2016)

Both GHK-Cu and Epithalon have strong safety profiles and are generally well tolerated

Rogic, V
